Harvest CSI Health Care and Medical 100 Strategy ETF (SHA:515960)
China · Delayed Price · Currency is CNY 0.8390
+0.0270 (3.33%)
Apr 1, 2026, 4:00 PM EDT
12.62% (1Y)
| Assets | 190.83M |
| Expense Ratio | 0.60% |
| PE Ratio | 22.89 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +12.62% |
| Volume | 10,588,200 |
| Open | 0.8200 |
| Previous Close | 0.8120 |
| Day's Range | 0.8160 - 0.8400 |
| 52-Week Low | 0.6700 |
| 52-Week High | 0.9540 |
| Beta | 0.43 |
| Holdings | 130 |
| Inception Date | Apr 24, 2020 |
About 515960
515960.SS was created on 2020-04-24 by Harvest. The fund's investment portfolio concentrates primarily on health care equity. The fund adopts the method of passive indexation investment, Closely track underlying index, Tightly track the target and minimize the deviation, and strive to keep the absolute value of the daily average tracking deviation not exceeding 0.2%, and the annualized tracking error not exceeding 2%.
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 515960
Provider Harvest
Index Tracked CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross
Performance
515960 had a total return of 12.62% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.76%.
Top 10 Holdings
41.56% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi AppTec Co., Ltd. | 603259 | 8.01% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 600276 | 7.72% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 300760 | 7.70% |
| Aier Eye Hospital Group Co., Ltd. | 300015 | 3.45% |
| Yunnan Baiyao Group Co.,Ltd | 000538 | 3.41% |
| Zhejiang NHU Company Ltd. | 002001 | 2.61% |
| Huadong Medicine Co., Ltd | 000963 | 2.33% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 600196 | 2.27% |
| BeOne Medicines AG | 688235 | 2.07% |
| Pharmaron Beijing Co., Ltd. | 300759 | 1.98% |